Ray, Arghya

Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism.

Schauer, N. J., Liu, X., Magin, R. S., Doherty, L. M., Chan, W. C., Ficarro, S. B., Hu, W., Roberts, R. M., Iacob, R. E., Stolte, B., et al. (2020) · Scientific Reports

Ubiquitin and proteasome pathwaysCancer-related Molecular Pathways

Cited by 125

Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD®immunomodulatory drug pomalidomide

Das, D. S., Ray, A., Song, Y., Richardson, P., Trikha, M., Chauhan, D., & Anderson, K. C. (2015) · British Journal of Haematology

Multiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors

Cited by 49

Purification and Characterization of a Transmembrane Domain-Deleted Form of Lecithin Retinol Acyltransferase

Bok, D., Ruiz, A., Yaron, O., Jahng, W. J., Ray, A., Xue, L., & Rando, R. R. (2003) · Biochemistry

Retinoids in leukemia and cellular processesPhotoreceptor and optogenetics research

Cited by 47